Mhealth in Tuberculosis Treatment: A new approach to improve adherence

Authors

  • Dr. T. Rajavardhana Balaji College of Pharmacy, Ananthapuramu Author

DOI:

https://doi.org/10.61841/6nqcbv51

Keywords:

tuberculosis treatment:, a new approach to improve adherence

Abstract

Adherence to tuberculosis (TB) treatment is very important in promoting individual and public health. As Poor adherence may result in suffering, disease worsening and death as well as it again leads to increased economic burden to the patients as length of the treatment regimen increases and drug resistance develops.1 Exploring newer ways in improving adherence is very essential with growing non adherence. Mobile health (mHealth) holds considerable promise to improve quality and efficiency in health care.2 Yet its potential in Tuberculosis remains largely unexplored 3, 4. and there is a lack of patient-centered mHealth approaches in response to the complexity of real life.5 Also lacking are ethical evaluations of mHealth interventions6,7. The planning, implementation, and evaluation of mHealth interventions for Tuberculosis treatment adherence must be guided by values as much as by technical innovation.

 

Downloads

Download data is not yet available.

References

1. Schmidt H, Gostin LO, Emanuel EJ. Public health, universal health coverage, and Sustainable Development Goals: can they coexist? Lancet. 2015;386(9996):928-930.

2. Lewis T, Synowiec C, Lagomarsino G, Schweitzer J. E-health in low- and middle-income countries: findings from the Center for Health Market Innovations. Bull World Health Organ. 2012; 90(5):332-340.

3. World Health Organization (WHO). Digital health in the TB response: scaling up the TB response through information and communication technologies. Geneva: WHO; 2014. Available from: http://www.who.int/tb/publications/ehealth_TB.pdf

4. Denkinger CM, Grenier J, Stratis AK, Akkihal A, Pant-Pai N, Pai M. Mobile health to improve tuberculosis care and control: a call worth making. Int J Tuberc Lung Dis. 2013;17(6):719-727. CrossRef. Medline

5. van Gemert-Pinjen JEWC, Wynchank S, Covvey HD, Ossebaard HC. Improving the credibility of electronic health technologies. Bull World Health Organ. 2012;90(5):323-323A.

6. World Health Organization (WHO); International Telecommunication Union. National eHealth strategy toolkit. Geneva: WHO; 2012. Co-published by International Telecommunication Union. Available from: https://www.itu.int/ dms_pub/itu-d/opb/str/D-STR-E_HEALTH.05-2012-PDF-E.pdf

7. Kay M, Santos J, Takane M. mHealth: new horizons for health through mobile technologies. Geneva: World Health Organization; 2011. Available from: http://www.who.int/goe/ publications/goe_mhealth_web.pdf

8. World Health Organization (WHO). Global tuberculosis report 2015. Geneva: WHO; 2015. Available from: http://apps.who. int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf

9. World Health Organization (WHO) [Internet]. Geneva: WHO; c2016. Tuberculosis: fact sheet no. 104; reviewed 2016 Mar [cited 2015 Dec 18]. Available from: http://www.who.int/ mediacentre/factsheets/fs104/en/

10. World Health Organization (WHO). Treatment of tuberculosis: guidelines, 4th ed. Geneva: WHO; 2010. Available from: http://apps.who.int/iris/bitstream/10665/44165/1/ 9789241547833_eng.pdf

11. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta (GA): CDC. Drug-resistant TB; last updated 2016 Apr 13 [cited 2015 Dec 18]. Available from: http://www.cdc.gov/tb/ topic/drtb/default.htm

12. World Health Organization (WHO). Global strategy and targets for tuberculosis prevention, care and control after 2015: report by the Secretariat. Geneva: WHO; 2013. Available from: http:// apps.who.int/gb/ebwha/pdf_files/EB134/B134_12-en.pdf

13. Islam MA, May MA, Ahmed F, Cash RA. Making tuberculosis history: community-based solutions for millions. Dhaka (Bangladesh): University Press; 2011.

14. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238.

15. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lo¨nnroth K. Financial burden for tuberculosis patients in low- and middleincome countries: a systematic review. Eur Respir J. 2014; 43(6):1763-1775.

16. Johansson E, Long NH, Diwan VK, Winkvist A. Gender and tuberculosis control: perspectives on health seeking behaviour among men and women in Vietnam. Health Policy. 2000; 52(1):33-51. CrossRef. Medline

17. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta (GA): CDC. Latent tuberculosis infection: a guide for primary health care providers; last updated 2013 Apr 3 [cited 2015 Dec 18]. Available from: http://www.cdc.gov/tb/ publications/ltbi/treatment.htm

18. To¨ru¨n T, Gu¨ngo¨r G, Ozmen I, Bo¨lu¨kbas¸i Y, Maden E, Bic¸akc¸i B, et al. Side effects associated with the treatment of multidrugresistant tuberculosis. Int J Tuberc Lung Dis. 2005; 9(12):1373-1377. Medline

19. Datiko DG, Lindtjørn B. Cost and cost-effectiveness of treating smear-positive tuberculosis by health extension workers in Ethiopia: an ancillary cost-effectiveness analysis of community randomized trial. PLoS One. 2010;5(2):e9158.

20. World Bank Open Data [Internet]. Washington (DC): The World Bank; c2016. Mobile cellular subscriptions (per 100 people); [cited 2015 Jun 10]. Available from: http://data.worldbank. org/indicator/IT.CEL.SETS.P2

21. Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8(1):272

22. Center for Health Market Innovations (CHMI) [Internet]. Washington (DC): CHMI; c2016. TIBU: Year launched: 2012; [cited 2015 Dec 18]. Available from: http:// healthmarketinnovations.org/program/tibu

23. Boccia D, Hargreaves J, Lo¨nnroth K, Jaramillo E, Weiss J, Uplekar M, et al. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications. Int J Tuberc Lung Dis. 2011;15 Suppl 2:S34-S49.

24. Liu X, Lewis JJ, Zhang H, Lu W, Zhang S, Zheng G, et al. Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial. PLoS Med. 2015;12(9):e1001876.

25. Alwi, M. N. R. B., Ibrahim, M. I. B. M., Baharuddin, S. S. B., & Salahuddin, S. N. B. (2019). Exploring the perspective of health and well-being among orang asli: An evaluation of jakun. Test Engineering and Management, 81(11-12), 3477-3485. Retrieved from www.scopus.com

26. Agarkhed, J., & Ranjita, R. (2019). Smart health care system using wireless body area network. International Journal of Advanced Science and Technology, 27(1), 358-365. Retrieved from www.scopus.com

27. Agathiyar, M. P., & Sugumar, S. N. (2019). Concept of siddhars aimed at healthy longevity. International Journal of Advanced Science and Technology, 28(16), 2029-2033. Retrieved from www.scopus.com

28. Arifwidodo, S., & Chandrasiri, O. (2019). Urban heat island and health effects in bangkok, thailand. International Journal of Advanced Science and Technology, 28(1), 374-382. Retrieved from www.scopus.com

Downloads

Published

30.06.2020

How to Cite

Rajavardhana, D. T. (2020). Mhealth in Tuberculosis Treatment: A new approach to improve adherence. International Journal of Psychosocial Rehabilitation, 24(6), 7491-7496. https://doi.org/10.61841/6nqcbv51